Johan Neyts
Johan Neyts
Unknown affiliation
Verified email at
TitleCited byYear
Angiogenesis: regulators and clinical applications
S Liekens, E De Clercq, J Neyts
Biochemical pharmacology 61 (3), 253-270, 2001
The non‐immunosuppressive cyclosporin DEBIO‐025 is a potent inhibitor of hepatitis C virus replication in vitro
J Paeshuyse, A Kaul, E De Clercq, B Rosenwirth, JM Dumont, P Scalfaro, ...
Hepatology 43 (4), 761-770, 2006
The mannose-specific plant lectins from Cymbidium hybrid and Epipactis helleborine and the (N-acetylglucosamine) n-specific plant lectin from Urtica dioica are potent and …
J Balzarini, J Neyts, D Schols, M Hosoya, E Van Damme, W Peumans, ...
Antiviral research 18 (2), 191-207, 1992
HPMPC (cidofovir), PMEA (adefovir) and related acyclic nucleoside phosphonate analogues: a review of their pharmacology and clinical potential in the treatment of viral infections
L Naesens, R Snoeck, G Andrei, J Balzarini, J Neyts, E De Clercq
Antiviral Chemistry and Chemotherapy 8 (1), 1-23, 1997
An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus challenge
G Yang, DC Pevear, MH Davies, MS Collett, T Bailey, S Rippen, L Barone, ...
Journal of virology 79 (20), 13139-13149, 2005
Alpha-(1-3)-and alpha-(1-6)-D-mannose-specific plant lectins are markedly inhibitory to human immunodeficiency virus and cytomegalovirus infections in vitro.
J Balzarini, D Schols, J Neyts, E Van Damme, W Peumans, E De Clercq
Antimicrobial Agents and Chemotherapy 35 (3), 410-416, 1991
Perspectives for the Treatment of Infections withFlaviviridae
P Leyssen, E De Clercq, J Neyts
Clinical microbiology reviews 13 (1), 67-82, 2000
Structure and functionality in flavivirus NS-proteins: perspectives for drug design
M Bollati, K Alvarez, R Assenberg, C Baronti, B Canard, S Cook, ...
Antiviral research 87 (2), 125-148, 2010
Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties
P Proost, E Schutyser, P Menten, S Struyf, A Wuyts, G Opdenakker, ...
Blood 98 (13), 3554-3561, 2001
The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase
P Leyssen, J Balzarini, E De Clercq, J Neyts
Journal of virology 79 (3), 1943-1947, 2005
Selective inhibitors of picornavirus replication
AM De Palma, I Vliegen, E De Clercq, J Neyts
Medicinal research reviews 28 (6), 823-884, 2008
DEB025 (Alisporivir) inhibits hepatitis C virus replication by preventing a cyclophilin A induced cis-trans isomerisation in domain II of NS5A
L Coelmont, X Hanoulle, U Chatterji, C Berger, J Snoeck, M Bobardt, ...
PloS one 5 (10), e13687, 2010
Antiviral drug susceptibility of human herpesvirus 8.
J Neyts, E De Clercq
Antimicrobial Agents and Chemotherapy 41 (12), 2754-2756, 1997
The viral polymerase inhibitor 7-deaza-2˘-C-methyladenosine is a potent inhibitor of in vitro Zika virus replication and delays disease progression in a robust mouse infection …
J Zmurko, RE Marques, D Schols, E Verbeken, SJF Kaptein, J Neyts
PLoS neglected tropical diseases 10 (5), e0004695, 2016
Sulfated polymers inhibit the interaction of human cytomegalovirus with cell surface heparan sulfate
J Neyts, R Snoeck, D Schols, J Balzarini, JD Esko, A Van Schepdael, ...
Virology 189 (1), 48-58, 1992
Synthesis and antiviral activity evaluation of some new aminoadamantane derivatives. 2
N Kolocouris, A Kolocouris, GB Foscolos, G Fytas, J Neyts, E Padalko, ...
Journal of medicinal chemistry 39 (17), 3307-3318, 1996
Synthesis of new benzimidazole–coumarin conjugates as anti-hepatitis C virus agents
JR Hwu, R Singha, SC Hong, YH Chang, AR Das, I Vliegen, E De Clercq, ...
Antiviral Research 77 (2), 157-162, 2008
Antiviral agents active against human herpesviruses HHV‐6, HHV‐7 and HHV‐8
E De Clercq, L Naesens, L De Bolle, D Schols, Y Zhang, J Neyts
Reviews in medical virology 11 (6), 381-395, 2001
Inhibition of the replication of the DNA polymerase M550V mutation variant of human hepatitis B virus by adefovir, tenofovir, L‐FMAU, DAPD, penciclovir and lobucavir
D Clercq
Journal of viral hepatitis 7 (2), 161-165, 2000
Structure− activity relationship of new anti-Hepatitis C virus agents: Heterobicycle− coumarin conjugates
J Neyts, ED Clercq, R Singha, YH Chang, AR Das, SK Chakraborty, ...
Journal of medicinal chemistry 52 (5), 1486-1490, 2009
The system can't perform the operation now. Try again later.
Articles 1–20